By Greg Ryan ( July 2, 2013, 8:14 PM EDT) -- A New Jersey federal judge's ruling Thursday that claims related to Merck & Co. Inc.'s Fosamax are preempted by federal law will likely inspire other brand-name drug makers to mount the defense, which companies have forsaken following an unfavorable U.S. Supreme Court decision four years ago....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.